Staging and Grading Periodontitis

October 12th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Categories:   Coding   Dental  
0 Votes - Sign in to vote or comment.

We now understand periodontitis may present itself as a manifestation of systemic diseases in fact; according to DeltaDental, research shows that more than 90 percent of all systemic diseases have oral manifestations, including swollen gums, mouth ulcers, dry mouth, and excessive gum problems. Some of these diseases include:

  • Diabetes
  • Leukemia
  • Oral cancer
  • Pancreatic cancer
  • Heart disease
  • Kidney disease

Baby boomers are especially vulnerable to developing diabetes, osteoporosis, and heart disease, the risks of which increase with age. Researchers believe that symptoms of these conditions can manifest in the mouth, making dentists key in diagnosing the diseases. For example:

  • Bad breath and bleeding gums could be indicators of diabetes.
  • Dental x-rays can show the first stages of bone loss.
  • A sore and painful jaw could foreshadow an oncoming heart attack.

Continued research and findings supporting the association between periodontal disease and systemic disease assists with advancement toward improving outcomes and lowering risk factors.

In 1999 periodontitis was represented as a disease entity as either chronic or aggressive according to the ADA, however, this left out important biologic features to distinctly identify between the two and have since been regrouped simply as "periodontitis". We now classify based on staging the full mouth instead of severity alone.  In addition, we use grading to incorporate history, progression, and use risk factors as a way to determine the impact of a patient's general overall health. 

Staging Periodontitis

The following information on staging is available from the American Academy of Periodontology;

Stage I periodontitis (mild disease) patients will have probing depths ≤4 mm, CAL ≤1-2 mm, horizontal bone loss, and will require non-surgical treatment. No post-treatment tooth loss is expected, indicating the case has a good prognosis going into maintenance.

Stage II periodontitis (moderate disease) patients will have probing depths ≤5 mm, CAL ≤3-4 mm, horizontal bone loss, and will require non-surgical and surgical treatment. No post-treatment tooth loss is expected, indicating the case has a good prognosis going into maintenance.

Stage III periodontitis (severe disease) patients will have probing depths ≥6 mm, CAL ≥5 mm, and may have vertical bone loss and/or furcation involvement of Class II or III. This will require surgical and possibly regenerative treatments. There is the potential for tooth loss from 0 to 4 teeth. The complexity of the implant and/or restorative treatment is increased. The patient may require multi-specialty treatment. The overall case has a fair prognosis going into maintenance.

Stage IV periodontitis (very severe disease) patients will have probing depths ≥6 mm, CAL ≥5 mm, and may have vertical bone loss and/or furcation involvement of Class II or III. Fewer than 20 teeth may be present and there is the potential for tooth loss of 5 or more teeth. Advanced surgical treatment and/or regenerative therapy may be required, including augmentation treatment to facilitate implant therapy. Very complex implant and/or restorative treatment may be needed. The patient will often require multi-specialty treatment. The overall case has a questionable prognosis going into maintenance.

Factors Considered

  • CAL -interdental clinical attachment loss
  • Tooth Loss
  • Stage I and II - probing depths
  • Radiographic bone loss
  • Stage III and IV- furcation involvement, ridge defects, and bite collapse 

Other Considerations for Staging Periodontitis 

  • Staging pertains to the whole mouth and is relative to the area with the highest severity and most complex portion of the mouth.
  • Staging is based on the amount of damage that the disease has already progressed to. 
  • Tooth Loss or planned extractions due to Periodontitis is included as a part of active periodontal therapy. 
  • Each complexity moves the staging to the next higher stage.
  • Once a patient is clinically stable they are considered as having periodontal stability, the staging may develop to a higher stage, but not generally to a lower stage.

    NOTE:   According to the American Academy of Periodontology (AAP), "there is one exception to this rule. For instance, if the case was classified as Stage III due to the presence of a vertical defect ≥3 mm or Class II furcation involvement and those sites were successfully regenerated such that the CAL throughout the dentition is now 3-4 mm, the furcation involvement is a Class I or not clinically detectable, and probing depths are ≤5 mm, the stage could change from Stage III to Stage II."

Periodontitis Staging Table











≤4 mm

≤5 mm

≥6 mm

≥6 mm


≤1-2 mm

≤3-4 mm

≥5 mm

≥5 mm


Coronal third(<15%)

Coronal third(15-33%)

Extends beyond 33% or root

Extends beyond 33% of root







No Tooth Loss

No Tooth Loss

≤4 teeth

≥5 teeth


  • Non-surgical
  • Non-surgical
  • Surgical
  • Surgical
  • Possible regenerative
  • Possible multi-specialty care
  • Advanced surgical
  • Possible regenerative
  • Possible augmentation
  • Complex implant and/or restorative
  • Often multi-specialty care






Grading Periodontitis

The grading system helps us determine further progression and helps to identify at what rate the disease may progress. Grading also plays an important part in determining the anticipated response to treatment as well as the potential impact progression may have on their overall health.  Grading uses indicators of the disease and considers damage from any previous active disease. For example, is the patient a smoker or have diabetes? These are risk factors that will help determine the progression of the disease. There is also direct and indirect evidence of progression which is considered in grading such as the % of bone loss and the patient's age.   

Periodontitis Grading Table

Grade A:


Grade B:


Grade C:



No loss over 5 years

< 2 mm over 5 years

≥ 2 mm over 5 years


< 0.25

0.25 to 1.0

> 1.0


Low levels of destruction with biofilm deposits

Moderate levels of destruction with biofilm deposits

Excessive levels of destruction from biofilm deposits; clinical patterns denote rapid progression and/or early-onset disease



< 10 cigarettes/day

≥10 cigarettes/day


Normoglycemic/no diagnosis of diabetes

HbA1c < 7.0% in patients with diabetes

HbA1c ≥ 7.0% in patients with diabetes

Using both Staging and Grading for the Complete Picture

A patient may be in remission and considered a grade "A", which is an indication of low progression, or a slow rate but also have a stage III indicating previous damage.  Using both the staging and the grading gives a more complete assessment of the patient's risk and the expected progression, using an evidenced-based plan for treatment. 

We can see where a diabetic patient with HbA1c of 8.0% (grade C is HbA1c>7.0%) may be a Stage II but has a Grade C periodontitis.  Therefore, the diagnosis would be Stage II Grade C Periodontitis.


Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.

Latest articles:  (any category)

Delving Into the 360 Assessment Fraud Complaint
November 17th, 2021 - Jessica Hocker, CPC, CPB
The Department of Justice is pursuing claims of healthcare fraud against Cigna Health-Spring Medicare Advantage plan based on how they used data from their 360 Program in 2012. A review of the allegations may help other payers avoid similar accusations.
Lessons Learned from a RADV Audit Report
November 16th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
If given an opportunity to know ahead of time the questions that would be asked of you in an upcoming interview or quiz, it is likely the outcome would be significantly better than if you were surprised by the questions. This same concept may be applied to audits of risk ...
Changes in RPM for 2021! Now, Wait for it... New RTM Codes for 2022
November 11th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
Remote physiologic monitoring and clinical data monitoring is a relatively new concept thriving and growing as an essential component for telehealth services. According to global consumer trends, a company called Dynata reported, "Among the 39% of people who consulted a healthcare professional, two-thirds used telemedicine, many of them for the first time ...
Reporting and Auditing Drug Testing Services
November 9th, 2021 - Aimee Wilcox CPMA, CCS-P, CST, MA, MT
Drug testing is a common medical service used to manage prescription medications, verify someone is not taking illegal substances or too much of a prescribed substance, and monitor for toxicity and therapeutic dosing. It is customary for patients in treatment programs for chronic pain management or substance use disorders (SUD) to undergo random urine drug testing (UDT) or urine drug screening (UDS) as part of their individual treatment plan. Drug testing is regulated by federal and state laws (e.g., OSHA, CLIA), which must be carefully adhered to.
Understanding ASCs and APCs: Indicators and Place of Service
October 28th, 2021 - Christine Woolstenhulme, QCC, QMCS, CPC, CMRS
The decision regarding the most appropriate care setting for a given surgical procedure is determined by the physician based on the patient's individual clinical needs and preferences. Of course, there is a difference in reimbursement, and the billing depends on where the procedure took place, such as an office setting, inpatient ...
Are You Keeping up with the Official ICD-10-CM Guideline Changes for COVID-19?
October 25th, 2021 - Wyn Staheli, Director of Research
The COVID-19 public health emergency (PHE) has made it interesting and challenging for organizations to keep an eye on the evolving changes to the ICD-10-CM Official Guidelines for Coding and Reporting. Have you been keeping up with these changes?
Is Your Organization Ready to Deal with Provider Relief Fund (PRF) Audit Contractors?
October 15th, 2021 - Aimee Wilcox, CPMA, CCS-P, CST, MA, MT, Director of Content
Audits are currently underway to verify the monies distributed through the CARES Act were warranted and properly used by those organizations that received them. The federal government has contracted with financial institutions such as KPMG and PricewaterhouseCoopers, among others, to perform these audits referred to as Provider Relief Fund (PRF) audit contractors, funded with monies from the very same program. There were four phases of funding disbursements with phase 1 audits beginning in September. How ready are you to be audited?

Home About Contact Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2021 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association